Suppr超能文献

在全国合作胆结石研究(NCGS)中,鹅去氧胆酸对胆汁脂质的影响及其与胆结石溶解的关系。

The effects of chenodiol on biliary lipids and their association with gallstone dissolution in the National Cooperative Gallstone Study (NCGS).

作者信息

Grundy S M, Lan S P, Lachin J

出版信息

J Clin Invest. 1984 Apr;73(4):1156-66. doi: 10.1172/JCI111301.

Abstract

The National Cooperative Gallstone Study was a double-masked trial conducted to determine the efficacy and safety of chenodeoxycholic acid (chenodiol) for dissolution of cholesterol gallstones. Patients with radiolucent gallstones were randomly allocated to either a high dose (750 mg/d, n = 305) or low dose (375 mg/d, n = 306) of chenodiol or placebo (n = 305) administered for 2 yr. Specimens of gallbladder bile were obtained for biliary lipid analysis on 50% of all white obtained for biliary lipid analysis on 50% of all white patients at base line and after 3-mo therapy, on 45% at 12 mo, and on 36% at 24 mo. Among these specimens, 20% were inadequate for analysis. For analysis of data, available values during therapy were averaged up to time of dissolution, study exit, or study termination. In the high-dose group, percent chenodiol (molar percent of all bile acids) increased markedly and remained high during the 2 yr of follow-up. Also, molar percent cholesterol decreased significantly and remained low during the 2 yr of follow-up. In the low-dose group, percent chenodiol increased and remained significantly increased. Percent cholesterol saturation decreased at 3 mo, but at 24 mo it was not different from that in the placebo group, suggesting a physiological adaptation to the low dose by 2 yr. 79% of patients on high dose had greater than 70% chenodiol. Among these, half showed unsaturated bile (less than 100% cholesterol saturation) while the remainder were supersaturated; in the former group with unsaturated bile, 23% had complete dissolution and 51% had partial (greater than 50% reduction in stone size) or complete dissolution. In contrast, those with over 70% chenodiol and supersaturated bile had only 5% complete dissolution. Thus, development of unsaturated bile was a major factor associated with gallstone dissolution. The data also indicate that values for percent cholesterol saturation were a better predictor of gallstone dissolution than molar percent chenodiol, although a high percent chenodiol usually was required to obtain unsaturation.

摘要

全国胆石症合作研究是一项双盲试验,旨在确定鹅去氧胆酸(鹅脱氧胆酸)溶解胆固醇性胆结石的疗效和安全性。将射线可透过的胆结石患者随机分为高剂量组(750毫克/天,n = 305)、低剂量组(375毫克/天,n = 306)或安慰剂组(n = 305),给药2年。在基线时以及治疗3个月后,从所有白人患者的50%中获取胆囊胆汁样本进行胆汁脂质分析;12个月时从45%的患者中获取样本;24个月时从36%的患者中获取样本。在这些样本中,20%的样本分析不合格。为了分析数据,将治疗期间的可用值平均至结石溶解、研究退出或研究终止时。在高剂量组中,鹅去氧胆酸百分比(占所有胆汁酸的摩尔百分比)显著增加,并在2年的随访期间保持在较高水平。此外,胆固醇摩尔百分比显著下降,并在2年的随访期间保持在较低水平。在低剂量组中,鹅去氧胆酸百分比增加并持续显著升高。胆固醇饱和度百分比在3个月时下降,但在24个月时与安慰剂组无差异,这表明到2年时对低剂量产生了生理适应性。高剂量组中79%的患者鹅去氧胆酸含量超过70%。其中,一半患者的胆汁不饱和(胆固醇饱和度低于100%),其余患者的胆汁过饱和;在前一组不饱和胆汁患者中,23%的患者结石完全溶解,51%的患者结石部分溶解(结石大小减少超过50%)或完全溶解。相比之下,鹅去氧胆酸含量超过70%且胆汁过饱和的患者只有5%的结石完全溶解。因此,不饱和胆汁的形成是与胆结石溶解相关的主要因素。数据还表明,胆固醇饱和度百分比比鹅去氧胆酸摩尔百分比更能预测胆结石的溶解,尽管通常需要较高的鹅去氧胆酸百分比才能实现不饱和状态。

相似文献

4
Ursodiol: a cholesterol gallstone solubilizing agent.
Drug Intell Clin Pharm. 1988 Dec;22(12):941-5. doi: 10.1177/106002808802201202.
8
Medical dissolution of gallstones by oral bile acid therapy.
Am J Surg. 1989 Sep;158(3):198-204. doi: 10.1016/0002-9610(89)90252-3.

引用本文的文献

本文引用的文献

1
Design and methodological considerations in the National Cooperative Gallstone Study: a multicenter clinical trial.
Control Clin Trials. 1981 Sep;2(3):177-229. doi: 10.1016/0197-2456(81)90012-x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验